Clinical Research

Clinical Trials Drug Development Patient Care Epidemiology Patient Outcomes Randomized Controlled Trials Diagnostic Tools Meta-Analysis Observational Studies Drug Trials

HCW Biologics Prices Roughly $4 Million At‑The‑Market Private Placement

The sale aims to provide short-term cash to advance clinical programs plus to address debt obligations.

Ozone Cuts Lung-Growth Benefits of Vigorous Exercise in Children

Blood ‘Aging Clock’ in UK Biobank Tied to Higher Dementia Risk and Earlier Onset

Lancet Study Identifies Optimal Doses for Five ADHD Medications

Brain-Stimulating Contact Lenses Match Prozac in Mouse Depression Study

Fennec Q1 Sales Climb 73% to $15.1 Million on PEDMARK Momentum

30-Second Chair Test Linked to Higher Death Risk in Older Adults

BrainsWay Delivers Strong Q1, Reaffirms 2026 Outlook as Recurring Pipeline Builds

Ceribell Raises 2026 Outlook After 29% Q1 Revenue Jump and Record Hospital Adds

Monocyte Epigenetic Aging Linked to Cognitive Depression Symptoms

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

FDA Clears Motif Neurotech Trial of At-Home Brain Implant for Treatment-Resistant Depression

Placebo Pain Relief Traced to Brain’s Opioid Hub in Mice

Screening-Detected AF Carries Early, Threefold Heart Failure Risk in Swedish Trials

Study Finds Distinct Cardiometabolic Risks for Men and Women With Obesity

India Study Finds Widespread Antibiotic Resistance in Eye Infection Bacteria

Boston Scientific Slumps to 52-Week Low After Watchman Trial Jitters and Downgrade

Vitamin D Tied to Immune Shifts in IBD, Mayo-Led Study Finds

Lucid Diagnostics Sets Q4 Record as VA Contract Validates Pricing and Eyes Medicare Policy

Walking Pace Tops Simple Health Measures for Predicting Death Risk